R. W. Naeraa

发表

Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome.

Svend Juul, Knud Juel, Claus Højbjerg Gravholt, 2006, The Journal of clinical endocrinology and metabolism.

Inhibin A and B in adolescents and young adults with Turner's syndrome and no sign of spontaneous puberty.

N. Skakkebaek, A. Andersson, C. Gravholt, 2002, Human reproduction.

Prenatal and postnatal prevalence of Turner's syndrome: a registry study

C. Gravholt, J. Hansen, J. Hansen, 1996, BMJ.

Body Composition and Physical Fitness Are Major Determinants of the Growth Hormone-Insulin-Like Growth Factor Axis Aberrations in Adult Turner’s Syndrome, with Important Modulations by Treatment with 17β-Estradiol1

C. Gravholt, J. Christiansen, R. W. Naeraa, 1997 .

The effects of GH and hormone replacement therapy on serum concentrations of mannan-binding lectin, surfactant protein D and vitamin D binding protein in Turner syndrome.

S. Thiel, U. Holmskov, C. Gravholt, 2004, European journal of endocrinology.

Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.

L. Mosekilde, C. Gravholt, J. Jørgensen, 2002, Pediatrics.

Growth hormone and 17β-oestradiol treatment of Turner girls — 2-year results

J. Nielsen, R. W. Naeraa, K. Kastrup, 1994, European Journal of Pediatrics.

Effect of growth hormone and 17β‐oestradiol treatment on metabolism and body composition in girls with Turner syndrome

L. Mosekilde, C. Gravholt, J. Christiansen, 2005, Clinical endocrinology.

Morbidity in Turner syndrome.

C. Gravholt, J. Hansen, S. Juul, 1998, Journal of clinical epidemiology.

Occurrence of gonadoblastoma in females with Turner syndrome and Y chromosome material: a population study.

C. Gravholt, J. Müller, R. W. Naeraa, 2000, The Journal of clinical endocrinology and metabolism.

Skeletal size and bone mineral content in Turner's syndrome: Relation to karyotype, estrogen treatment, physical fitness, and bone turnover

L. Mosekilde, K. Brixen, P. Charles, 1991, Calcified Tissue International.

Effect of Oxandrolone on Growth and Final Height in Turner's Syndrome

J. Nielsen, R. W. Naeraa, I. Pedersen, 1990, Acta paediatrica Scandinavica.

Autoimmune diseases in Turner syndrome

L. Mazzanti, R. W. Naeraa, 2006 .

Standards for Growth and Final Height in Turner's Syndrome

J. Nielsen, R. W. Naeraa, R. Naeraa, 1990, Acta paediatrica Scandinavica.

Glucose Metabolism, Lipid Metabolism, and Cardiovascular Risk Factors in Adult Turner's Syndrome: The impact of sex hormone replacement

C. Gravholt, J. Christiansen, O. Schmitz, 1998, Diabetes Care.

Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.

J. Christiansen, R. W. Naeraa, S. Fisker, 1997, The Journal of clinical endocrinology and metabolism.

Prediction of Final Height in Turner's Syndrome A Comparative Study

J. Nielsen, R. W. Naeraa, M. Eiken, 1990, Acta paediatrica Scandinavica.